Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 64
	QLoRA Alpha: 64.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is an important predictor of neonatal morbidity. The current data suggest that BF% is more strongly associated with neonatal morbidity than birth weight percentile. Further studies are needed to determine whether BF% or birth weight percentile should be used as outcome measures for neonatal undernutrition. In addition, BF% may be a better marker for undernutrition in neonates than birth weight because it reflects both lean mass and adipose tissue deposition, which may have different effects on neurological development and metabolic function. Future studies should investigate the relationship between BF%, nutrient intake, and neurodevelopmental outcomes in infants who are undernourished at birth.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.8
Reasoning:
The assistant's answer correctly states the main conclusion of the study — that neonatal body fat percentage (BF%) is more strongly associated with neonatal morbidity than birth weight percentiles — and appropriately notes that further studies are needed. It omits the specific point from the ground truth that BF% can identify neonates who are appropriately grown yet undernourished and can exclude small neonates not at risk. One minor imprecision is the phrasing that BF% “reflects both lean mass and adipose tissue deposition” (BF% primarily quantifies adiposity as a proportion of body mass rather than directly measuring lean mass). Overall the response is accurate and appropriately cautious. 


conciseness: 0.7
Reasoning:
The assistant’s reply directly answers the question (saying BF% is more strongly associated with neonatal morbidity than birth weight percentiles) and is generally concise, but it includes some additional speculative points (mechanistic rationale and calls for future research) that are not needed to answer the question. It could be slightly more to-the-point by simply stating that BF% appears to be the better measure based on the presented data. 

relevance: 0.8
Reasoning:
The assistant's reply directly answers the question (saying BF% is more strongly associated with neonatal morbidity than birth weight percentiles) and accurately reflects the study's conclusion. However, it does not quote or cite the specific sentence or numeric results from the context (for example the reported ORs or the ground-truth sentence stating BF% more closely identifies neonates at risk), and it adds some speculative commentary (about lean mass, neurological development and nutrient-intake relationships) that goes beyond the provided text.

coherence: 0.8
Reasoning:
The assistant's reply is overall coherent and well organized: it directly answers the question (states BF% appears more strongly associated with neonatal morbidity than birth weight percentiles), summarizes implications (may be a better marker) and advises further study. Strengths include concision, clear conclusion, and appropriate caveat calling for additional research. Weaknesses in coherence are minor: it omits specific study data that would strengthen the claim, and one sentence imprecisely implies BF% "reflects both lean mass and adipose tissue" (BF% specifically quantifies fat proportion rather than directly measuring lean mass). 

helpfulness: 0.8
Reasoning:
The assistant's reply correctly states that low BF% is more strongly associated with neonatal morbidity than birth weight percentiles and answers the question directly. It helpfully notes the need for further study and offers a plausible rationale (body composition vs weight alone). However it omits useful study details (effect sizes, prevalence, and the specific finding that BF% can identify appropriately grown but undernourished neonates and exclude small neonates not at risk) and contains a minor imprecision about BF% "reflecting both lean mass and adipose tissue" (BF% specifically describes proportion of fat mass, while body composition assessments distinguish fat and fat‑free mass). Overall the response is concise and mostly accurate but could be improved with the study's quantitative results and a clearer description of what BF% measures.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The results of this study suggest that it may be possible to salvage the limb in most cases of ischemic Charcot neuroarthropathy, but the duration to heal the lesion can vary. This study did not show any significant difference in treatment outcome between ischemic Charcot neuropathy and other types of Charcot neuropathy. Therefore, we suggest that it is important to perform an early diagnosis of the cause of the foot lesion and to start prompt treatment to avoid complications such as critical limb ischemia. We believe that this study should encourage physicians to consider this type of treatment option for their patients with diabetes mellitus who have ischemic Charcot neuropathy and foot ulcers. Our results also suggest that it is important to monitor the patient's condition closely during the treatment period and to change the treatment plan accordingly. Further studies will be needed to confirm these results and to investigate the long-term effects of this treatment.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.3
Reasoning:
The assistant's reply is imprecise and partially incorrect. It fails to state the key point supported by the study and ground truth — that ischemic Charcot foot commonly requires revascularization to support surgical/orthopedic treatment and achieve limb/foot salvage — and instead incorrectly asserts there was "no significant difference" in outcomes versus non‑ischemic Charcot. It also omits the study's main results (90% limb salvage, mean healing time ≈197 days) and does not clearly answer whether ischemic Charcot is a different entity requiring different management. Overall the response is vague, misleading on a central point, and incomplete.

conciseness: 0.3
Reasoning:
The assistant's reply is verbose and indirect: it repeats general advice (early diagnosis, close monitoring) without directly answering whether ischemic Charcot is a distinct entity requiring different treatment. It also fails to state the key point supported by the data — that revascularization is necessary to enable surgical/orthopedic treatment and improve limb salvage — and instead makes an unsupported claim about no difference in outcomes. Overall it is not concise or to the point.

relevance: 0.3
Reasoning:
The assistant's reply is only weakly relevant. It addresses limb salvage and the need for prompt treatment but makes an unsupported claim that "this study did not show any significant difference" between ischemic and other Charcot neuropathies (the provided context contains no such comparison). It also fails to cite key results from the context (for example, limb salvage 90% and mean healing time ~197 days) that would directly support an answer about whether ischemic Charcot requires different treatment (revascularization). Overall the response partially answers the question but lacks grounding in the quoted data and includes unsupported statements.

coherence: 0.4
Reasoning:
The assistant's reply is generally coherent but only partially answers the question. It summarizes that limb salvage is possible and emphasizes early diagnosis, close monitoring, and need for further studies, which is reasonable given the study context. However, it fails to directly address whether ischemic Charcot foot is a distinct entity requiring different treatment: it wrongly asserts "no significant difference" in outcomes without evidence from the provided data (which only reports ischemic cases), and it does not clearly state the key clinical implication from the ground truth — that revascularization is often necessary to support surgical/orthopedic treatment and avoid amputation. The response is repetitive and somewhat vague rather than providing a clear, structured answer to the posed question.

helpfulness: 0.3
Reasoning:
The assistant's reply is vague and partly inaccurate. It fails to state the key clinical point supported by the study and ground truth: ischemic Charcot foot is a distinct, higher‑risk situation that typically requires vascular assessment and revascularization before or as part of surgical/orthopedic management to improve limb salvage. Instead the reply incorrectly asserts "no significant difference" in outcomes between ischemic and non‑ischemic Charcot disease, omits the study's concrete findings (90% limb salvage, mean healing time ≈197 days), and gives only generic recommendations about early diagnosis and monitoring. These shortcomings reduce its usefulness for clinicians deciding whether ischemic Charcot requires different treatment.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Although there is no significant difference in oncological outcomes after radical hysterectomy or mastectomy for early-stage breast cancer, RH may be more effective than mastectomy in terms of minimizing morbidity. Therefore, we recommend RH as the standard treatment for endometrial cancer with suspected cervical involvement. However, further studies are required to confirm this finding. We believe that RH is necessary for optimal management of endometrial cancer with cervical involvement. This study highlights the need for further prospective studies to evaluate the role of RH for endometrial cancer with suspected cervical involvement. Further studies should focus on comparing the clinical outcome of RH versus mastectomy in terms of disease-free survival, morbidity, and quality of life. To our knowledge, this is the first report of RH for endometrial cancer with suspected cervical involvement. Future investigations should explore the possibility of RH for endometrial cancer with suspected cervical involvement. If possible, we would like to conduct an intervention trial to compare RH with mastectomy. Furthermore, we aim to determine whether the use of RH improves long-term survival for patients with endometrial cancer with suspected cervical involvement. Such a study will provide valuable insights into the best approach for treating endometrial cancer with cervical involvement.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.1
Reasoning:
The assistant's reply is incorrect and largely irrelevant. It repeatedly and incorrectly compares radical hysterectomy (RH) for endometrial cancer to mastectomy (a breast cancer procedure), makes unsupported recommendations that RH should be standard care, and contradicts the study findings (the GOTIC-005 analysis found type of hysterectomy was not an independent prognostic factor and RH had more perioperative and late adverse events with no survival benefit). The response contains fabrications and fails to accurately summarize or interpret the study.

conciseness: 0.2
Reasoning:
The assistant's reply is neither concise nor on point. It is verbose and repetitive, includes irrelevant comparisons to mastectomy and breast cancer, and repeatedly advocates radical hysterectomy despite the study's findings that type of hysterectomy was not an independent prognostic factor and RH had more adverse events. It fails to provide a direct, succinct answer summarizing the GOTIC study results.

relevance: 0.1
Reasoning:
The assistant's reply is not relevant to the provided study and contains multiple factual and logical errors. It repeatedly and incorrectly compares radical hysterectomy (RH) for endometrial cancer to mastectomy for breast cancer (an irrelevant analogy), claims RH is necessary and the standard treatment despite the study finding no survival benefit and identifying no prognostic effect of hysterectomy type, and ignores the reported higher perioperative and late adverse events with RH. The response does not cite or accurately reflect the study findings and proposes inappropriate future comparisons (RH versus mastectomy). 

coherence: 0.1
Reasoning:
The response is incoherent and factually incorrect. It repeatedly and incorrectly compares radical hysterectomy (RH) for endometrial cancer to mastectomy for breast cancer (an irrelevant and inappropriate analogy), draws the opposite conclusion to the study (recommending RH as standard despite the study finding no survival benefit and increased adverse events with RH), and repeats the same unsupported proposals several times. It fails to summarize the study's actual findings (no prognostic effect of hysterectomy type, more perioperative/late adverse events with RH, and no survival benefit) and therefore does not answer the question accurately or usefully.

helpfulness: 0.1
Reasoning:
Explanation:
The assistant's reply is incorrect and misleading. It repeatedly and erroneously compares radical hysterectomy (RH) for endometrial cancer to mastectomy and breast cancer, which is irrelevant. It also contradicts the study findings by recommending RH as standard care despite the GOTIC-005 results showing that hysterectomy type was not an independent prognostic factor and that RH incurred greater perioperative and late morbidity without survival benefit. The response fails to summarize the actual study conclusions (no survival advantage for RH; more adverse events with RH) and instead proposes inappropriate comparisons and trials (RH vs mastectomy), so it is not a helpful or accurate answer.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions are an important indicator of the quality of care provided by surgeons and institutions. Pancreaticoduodenectomy is a complex procedure that requires meticulous attention to detail and close monitoring of patients' postoperative course. Although PD readmissions may be attributable to various causes, there are several key factors that could be addressed to reduce their incidence. These include early identification and management of complications, optimal timing of discharge, and improved communication among physicians and patients. Furthermore, the use of standardized protocols for PD might facilitate consistent practice and improve patient outcomes. Future studies should focus on developing and testing strategies for reducing PD readmissions. However, the development of guidelines for perioperative care would be crucial to improving outcomes and reducing readmissions. Moreover, such guidelines could help improve consistency across institutions, which would ultimately benefit patients. In addition, these guidelines could provide a framework for surgeons and hospitals to evaluate their own practices and identify areas for improvement. By implementing evidence-based protocols for PD, we can enhance patient safety, reduce costs, and improve clinical outcomes. To improve patient outcomes, it will be necessary to develop and test a comprehensive bundle of interventions to minimize PD readmissions. This bundle must encompass a wide range of elements that affect patient care during the perioperative period. These elements include preoperative optimization, pain control, nutritional support, timely discharge planning, and prompt management of complications. Additionally, the development of a standardized protocol for perioperative care may help ensure that all patients receive the same level of care, regardless of the institution where they undergo PD. Such a protocol will also aid in identifying potential pitfalls in the current approach to PD care. Once this bundle is developed, its efficacy should be tested in a prospective, randomized trial. This study design will allow us to determine whether the bundle improves outcomes relative to standard care. Furthermore, such a trial will enable us to determine how cost-effective the bundle is and identify any additional resources needed to implement it. The results of this trial will be instrumental in determining the best strategy for reducing PD readmissions.
In summary, the incidence of readmissions following PD is high enough to warrant serious consideration of the problem. Our findings suggest that optimizing perioperative care may lead to reduced readmissions. Therefore, we should strive to develop guidelines and implement standardized protocols that address the issues that contribute to readmissions. Only then will we be able to achieve significant improvements in patient outcomes and reduce health-care costs.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.3
Reasoning:
The assistant's reply gives reasonable general suggestions (standardized protocols, perioperative optimization, better discharge planning) that could help reduce readmissions, but it fails to state the study's key, evidence-based findings: that pancreatic fistula and complexity of the initial resection (multivisceral resection) were independent predictors of readmission, and that half of readmissions occur within 7 days (early readmissions) with different predominant causes than late readmissions. Because it omits these specific, important results and the recommendation to focus on preventing early readmissions, the response is incomplete and only partially aligned with the ground truth.

conciseness: 0.3
Reasoning:
The assistant's reply is verbose and repetitive and therefore not concise. It gives broad, generic prevention strategies but fails to mention the key, specific findings from the study (pancreatic fistula and complex/multivisceral resection as independent predictors, and that ~50% of readmissions occur within 7 days), so it does not directly or succinctly answer the question in light of the provided data.

relevance: 0.3
Reasoning:
The assistant's reply offers reasonable, general strategies to reduce readmissions after PD (standardized protocols, perioperative bundles, improved discharge planning, prospective testing), so it is broadly relevant to the question of prevention. However, it fails to reference the specific, real findings from the provided context — notably that pancreatic fistula and complexity of resection (multivisceral resection) were independently associated with readmission, and that half of readmissions occur within 7 days — and therefore does not tie its recommendations to the key risk factors or the emphasis on preventing early readmissions contained in the study. Because relevance to the question is present but the response did not use the actual contextual evidence, the evaluation is low–moderate.

coherence: 0.6
Reasoning:
The assistant reply is generally coherent and well organized: it answers the question by outlining broad prevention strategies (early complication recognition, optimized discharge timing, standardized perioperative bundles, improved communication) and recommends testing interventions prospectively. However, it is fairly generic and repetitive, and it does not engage with key study findings (that complexity of resection and pancreatic fistula independently predict readmission, or that half of readmissions are early and may require targeted prevention). It therefore misses important, actionable specifics tied to the provided data (for example, measures to prevent or manage pancreatic fistula, or focused strategies to reduce early ≤7‑day readmissions).

helpfulness: 0.3
Reasoning:
The assistant's reply is generic and mostly discusses broad strategies (standardized protocols, perioperative bundles, randomized trials) rather than addressing the study's specific findings. It fails to note the key independent predictors identified (complexity of the initial resection and pancreatic fistula) and does not emphasize that half of readmissions occur within 7 days — a clear target for prevention. While the suggestions are reasonable at a high level, the response lacks specificity, direct linkage to the reported data, and concrete, actionable measures tied to the identified risk factors.

================================================================================
Average correctness Score: 0.5
Average conciseness Score: 0.485
Average relevance Score: 0.54
Average coherence Score: 0.6
Average helpfulness Score: 0.495
